In the last week, the Clinical Research and Equipment industry is up 2.4%, with Divi's Laboratories up 4.5%. In the same time, Dishman Carbogen Amcis was down 15%. This means that the industry has gained 16% over the past year. Looking forward, earnings are forecast to grow by 22% annually.
Has the Indian Clinical Research and Equipment Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sat, 01 Jun 2024 | ₹1.7t | ₹195.1b | ₹21.6b | 31.8x | 76.4x | 8.5x |
Mon, 29 Apr 2024 | ₹1.5t | ₹167.8b | ₹18.7b | 30.8x | 79.5x | 8.9x |
Wed, 27 Mar 2024 | ₹1.3t | ₹168.5b | ₹18.6b | 28.1x | 70.5x | 7.8x |
Fri, 23 Feb 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 31.3x | 75.9x | 8.4x |
Sun, 21 Jan 2024 | ₹1.4t | ₹165.9b | ₹18.9b | 31.6x | 74.2x | 8.4x |
Tue, 19 Dec 2023 | ₹1.4t | ₹155.9b | ₹18.1b | 21.7x | 75.3x | 8.7x |
Thu, 16 Nov 2023 | ₹1.3t | ₹156.5b | ₹18.1b | 22x | 73x | 8.4x |
Sat, 14 Oct 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 25.7x | 70.9x | 9x |
Mon, 11 Sep 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 26.6x | 71.7x | 9.1x |
Wed, 09 Aug 2023 | ₹1.4t | ₹158.1b | ₹23.2b | 30.5x | 62.1x | 9.1x |
Fri, 07 Jul 2023 | ₹1.4t | ₹157.2b | ₹23.0b | 28.5x | 60.1x | 8.8x |
Sun, 04 Jun 2023 | ₹1.3t | ₹157.6b | ₹23.1b | 37.9x | 56.4x | 8.3x |
Tue, 02 May 2023 | ₹1.2t | ₹162.6b | ₹28.7b | 34.4x | 42.5x | 7.5x |
Thu, 30 Mar 2023 | ₹1.1t | ₹159.5b | ₹28.4b | 31.1x | 37x | 6.6x |
Sat, 25 Feb 2023 | ₹1.1t | ₹159.5b | ₹28.4b | 32.3x | 38x | 6.8x |
Mon, 23 Jan 2023 | ₹1.2t | ₹164.9b | ₹34.5b | 29.7x | 35.2x | 7.4x |
Wed, 21 Dec 2022 | ₹1.2t | ₹164.9b | ₹34.5b | 30.6x | 34.9x | 7.3x |
Fri, 18 Nov 2022 | ₹1.2t | ₹163.9b | ₹34.8b | 29.2x | 34.6x | 7.4x |
Sun, 16 Oct 2022 | ₹1.3t | ₹162.5b | ₹35.7b | 36.3x | 35.1x | 7.7x |
Tue, 13 Sep 2022 | ₹1.3t | ₹162.5b | ₹35.7b | 38.3x | 36.3x | 8x |
Thu, 11 Aug 2022 | ₹1.4t | ₹159.0b | ₹34.3b | 35.4x | 39.8x | 8.6x |
Sat, 09 Jul 2022 | ₹1.3t | ₹158.3b | ₹34.2b | 32.9x | 37.9x | 8.2x |
Mon, 06 Jun 2022 | ₹1.2t | ₹158.3b | ₹34.2b | 31.2x | 35.7x | 7.7x |
Wed, 04 May 2022 | ₹1.5t | ₹149.3b | ₹29.2b | 34.6x | 52.6x | 10.3x |
Fri, 01 Apr 2022 | ₹1.5t | ₹148.3b | ₹29.4b | 33.4x | 51.6x | 10.2x |
Sun, 27 Feb 2022 | ₹1.4t | ₹148.3b | ₹29.4b | 31.7x | 48.1x | 9.5x |
Tue, 25 Jan 2022 | ₹1.4t | ₹138.5b | ₹24.7b | 39.9x | 57.5x | 10.2x |
Thu, 23 Dec 2021 | ₹1.6t | ₹137.8b | ₹24.6b | 30.3x | 63.2x | 11.3x |
Sat, 20 Nov 2021 | ₹1.6t | ₹135.3b | ₹23.7b | 28.8x | 67.2x | 11.8x |
Mon, 18 Oct 2021 | ₹1.8t | ₹131.1b | ₹22.9b | 22x | 76.6x | 13.4x |
Wed, 15 Sep 2021 | ₹1.7t | ₹131.1b | ₹22.9b | 24.6x | 74.6x | 13.1x |
Fri, 13 Aug 2021 | ₹1.6t | ₹127.1b | ₹22.6b | 40.3x | 72.2x | 12.8x |
Tue, 08 Jun 2021 | ₹1.4t | ₹121.4b | ₹21.5b | 39.6x | 65.8x | 11.7x |
65.8x
How does Indian Clinical Research and Equipment compare with similar industries?
IN Market | -1.89% | |
Healthcare | -1.46% | |
Life Sciences | 2.40% | |
Clinical Research and Equipment | 2.40% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
DIVISLAB Divi's Laboratories | ₹4.31k | 4.5% +₹49.1b | 22.7% | PE82.7x | |
WINDLAS Windlas Biotech | ₹632.10 | 2.2% +₹289.1m | 125.0% | PE22.6x | |
538837 Jeevan Scientific Technology | ₹49.57 | 2.9% +₹21.4m | 8.7% | PS2.1x |